Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia.

Joshi, Jaitri; Tanner, Lynn; Gilchrist, Laura; Bostrom, Bruce

Joshi, Jaitri; Tanner, Lynn; Gilchrist, Laura; Bostrom, Bruce.

Affiliation

Joshi J; Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.

J Pediatr Hematol Oncol ; 41(6): 457-462, 2019 08.

Article in En | MEDLINE | ID: mdl-31233464

Subject(s)

Antineoplastic Agents, Phytogenic/adverse effects; Antineoplastic Agents/therapeutic use; Bortezomib/therapeutic use; Drug Substitution/statistics & numerical data; Nervous System Diseases/prevention & control; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Vincristine/adverse effects; Adolescent; Adult; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Nervous System Diseases/chemically induced; Nervous System Diseases/pathology; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology; Prognosis; Retrospective Studies; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vincristine / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Drug Substitution / Bortezomib / Nervous System Diseases / Antineoplastic Agents / Antineoplastic Agents, Phytogenic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: J Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2019 Type: Article Affiliation country: Mongolia

Fulltext

XML

PubMed Links

Search on Google